Previous 10 | Next 10 |
ICON PLC is a Contract Research Organization that generated revenues of $2.8bn in FY20, and whose share price is +173% over a five-year period. Having potentially reached its rapid growth ceiling, the company has taken the decision to acquire its closest-matched sector rival PRA Healt...
Wells Fargo analyst Dan Leonard has upgraded shares of clinical research organization ICON plc (ICLR) from equal weight to overweight and is bumping up his price target to $235 from $200.Based on yesterday's closing price, that represents upside of ~20%.Leonard's bullishness is based on the c...
Gilead Sciences (GILD) is trading ~1.6% higher in the pre-market after Bernstein upgraded the stock to outperform from market perform.The analyst Aaron Gal expects that company to generate future catalysts and growth drivers the lack of which led the stock to remain undervalued in the pa...
Healthcare supply chain and pharma services companies weathered the COVID-19 volatility fairly well, and adapted to new realities along the way, Baird notes with the Q4 results in the rear-view mirror. The contract research organizations posted constant-dollar organic revenue growth of 10.2% ...
ICON plc , (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that Mr. Brendan Brennan, CFO of ICON plc, will prese...
CFRA analyst Sel Hardy has upgraded ICON Public Limited ([[ICLR]] +3.5%) to hold from sell noting that the stock witnessed more than a tenth of a decline in value since the previous sell call in the wake of its merger agreement with PRA Health.The price target, lowered to $178.00 from $1...
Merger activity increased last week. Six multi-billion-dollar deals announced. SPAC frenzy hits a new record. For further details see: Merger Arbitrage Mondays: SPAC IPOs Set A New Record
ICON Public Limited Company (ICLR) Q4 2020 Earnings Conference Call February 25, 2020 09:00 AM ET Company Participants Jonathan Curtain - VP Corporate Finance & IR Steve Cutler - CEO Brendan Brennan - CFO Colin Shannon - Chairman and CEO, PRA Health Sciences Conference Call Participants R...
The following slide deck was published by ICON Public Limited Company in conjunction with their 2020 Q4 earnings call. For further details see: ICON Public Limited Company 2020 Q4 - Results - Earnings Call Presentation
Immediate reaction to yesterday's announcement of a big merger of healthcare contract research organizations has Baird raising targets on each company, saying it looks like two good firms with an interesting case for coming together. Initial feedback on the deal for ICON plc's (ICLR) $12B acq...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...